BioCampus Cologne with its property area of 254.000 square meters will be one of the largest biotechnology parks in Germany. BioCampus Cologne offers Life-Science companies a pre-financed infrastructure, S1 and S2 laboratory facilities ready for occupancy with associated office space and sufficient expansion possibilities. Utilization of the shared facilities, such as the representative conference center on the eleventh floor in one of the buildings on campus, the campus restaurant with catering services and the 24/7 security service, relieve the organizational and financial burden on the companies. Until now, successful companies from the life science sector like Axiogenesis AG, AyoxxA Biosystems GmbH, Bayer HealthCare, DIREVO Industrial Biotechnology GmbH, Lonza Cologne AG, Metabolix GmbH, Nexigen GmbH, Sividon Diagnostic GmbH or A. Nattermann & Cie. GmbH / sanofi aventis profit from BioCampus Cologne’s advantages.